Merck’s V116 Pneumococcal Vaccine Shows Promising Data Against Pfizer’s Prevnar 20
Merck, Sharp & Dohme (MSD; NYSE: MRK) has unveiled new data from a late-stage trial...
China’s Pharma Distribution Market Grows Steadily in 2022, Driven by Retail Sales Surge
The Ministry of Commerce (MofCOM) has released its annual statistical review of China’s pharmaceutical distribution...
BMS and Avidity Biosciences Join Forces on $2.2 Billion Cardiology Antibody Oligonucleotide Conjugate Deal
Bristol Myers Squibb (BMS, NYSE: BMY) has announced a strategic partnership with Avidity Biosciences (NASDAQ:...
Blue Sail Medical and China National Medical Device Forge Strategic Partnership for Growth
Blue Sail Medical Co., Ltd (SHE: 002382), a prominent player in China’s medical device sector,...
Alibaba Health Reports 12.7% Revenue Growth in H1 2023, Driven by Pharmaceutical and Digital Services
Alibaba Health Information Technology Ltd (HKG: 0241), based in China, has released its financial results...
JW Therapeutics Secures Priority Review for Carteyva in Relapsed/Refractory Mantle Cell Lymphoma
JW Therapeutics (HKG: 2126), based in China, has announced that its CAR-T cell therapy, Carteyva...
Beijing Konruns Pharmaceutical Launches Phase III Study for KC1036 in Advanced Esophageal Cancer
Beijing Konruns Pharmaceutical Co., Ltd (SHA: 603590), based in Beijing, has received approval from China’s...
Lee’s Pharmaceutical Secures NMPA Approval for Adasuve, Pioneering Loxapine Inhaler for Agitation
Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) has secured marketing approval from China’s National Medical Products...
AK Medical Holdings Receives NMPA Approval for Hip Surgery Navigation System iBot
AK Medical Holdings Ltd (HKG: 1789), a Chinese medical technology company, has announced that it...
Gracell Biotechnologies Gets FDA Green Light for FasTCAR-T Therapy in Systemic Lupus Erythematosus
Gracell Biotechnologies Inc., a Suzhou-based biotech company (NASDAQ: GRCL), has received approval from the US...
Mabwell Bioscience Enters Thai Market with Licensing Deal with Innobic
Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a Chinese biopharmaceutical company, has announced the signing...
Taihe Weiye Biotechnology Secures RMB 300 Million in Series A+ Financing to Expand Production
Chengdu Taihe Weiye Biotechnology Co., Ltd, a Chinese developer of protected amino acids drugs, has...
Dupixent Trial Success Reinforces Potential in Moderate-to-Severe COPD Treatment
Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi (NASDAQ: SNY) have announced that a late-stage replicate trial...
AbbVie’s Epcoritamab Earns EMA Review and FDA Breakthrough Designation for Follicular Lymphoma
AbbVie’s (NYSE: ABBV) bispecific antibody (BsAb) Tepkinly/Epkinly (epcoritamab) has been accepted for review by the...
AstraZeneca to Open R&D Center in Hong Kong, Focusing on Cell and Gene Therapies
UK pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) has concluded a roughly 12-month discussion period with...
Bayer Faces Backlash After Bond Sale Preceding Late-Stage Pipeline Failure
German pharmaceutical giant Bayer (ETR: BAYN) is facing investor and analyst scrutiny following its issuance...
Everest Medicines’ Nefecon for IgAN Receives NMPA Approval in China
Everest Medicines (HKG: 1952), a China-based pharmaceutical company, has announced that its New Drug Application...
Beijing QL Biopharmaceutical Boosts Pipeline with RMB 200 Million Series B+ Round
Beijing QL Biopharmaceutical Co., Ltd., a Chinese biopharmaceutical company, has reportedly secured nearly RMB 200...
Henlius Biotech Gets FDA Clearance for Clinical Study of PD-L1 Targeting ADC HLX43
Shanghai Henlius Biotech Inc. (HKG: 2696), a Chinese biopharmaceutical company, has received approval from the...
CSPC Pharmaceutical Gets NMPA Green Light for SYH2038 Solid Tumor Study
CSPC Pharmaceutical Group Ltd (HKG: 1093), a Chinese pharmaceutical company, has announced that it has...